Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab

被引:13
作者
Canfield, SD [1 ]
Simoes, EAF [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Infect Dis Sect, Denver, CO USA
来源
PEDIATRIC ANNALS | 1999年 / 28卷 / 08期
关键词
D O I
10.3928/0090-4481-19990801-08
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Respiratory syncytial virus can be life threatening for infants. This article discusses the passive immunization options of respiratory syncytial virus immune globulin intravenous and palivizumab, including the benefits and the costs, and identifies the high-risk groups that should be considered for treatment.
引用
收藏
页码:507 / +
页数:9
相关论文
共 18 条
  • [1] NEUTRALIZATION EPITOPES OF THE F-GLYCOPROTEIN OF RESPIRATORY SYNCYTIAL VIRUS - EFFECT OF MUTATION UPON FUSION FUNCTION
    BEELER, JA
    COELINGH, KV
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (07) : 2941 - 2950
  • [2] BRANCO L, 1999, EUR SOC INF DIS CRET
  • [3] Connor E, 1997, PEDIATRICS, V99, P93
  • [4] DINGIVAN CA, 1998, BIOTECH MED MANAGEME, V2, P11
  • [5] PROPHYLACTIC ADMINISTRATION OF RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN TO HIGH-RISK INFANTS AND YOUNG-CHILDREN
    GROOTHUIS, JR
    SIMOES, EAF
    LEVIN, MJ
    HALL, CB
    LONG, CE
    RODRIGUEZ, WJ
    ARROBIO, J
    MEISSNER, HC
    FULTON, DR
    WELLIVER, RC
    TRISTRAM, DA
    SIBER, GR
    PRINCE, GA
    VANRADEN, M
    HEMMING, VG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (21) : 1524 - 1530
  • [6] Halsey NA, 1997, PEDIATRICS, V99, P645, DOI 10.1542/peds.99.4.645
  • [7] Halsey NA, 1998, PEDIATRICS, V102, P1211, DOI 10.1542/peds.102.5.1211
  • [8] Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus
    Johnson, S
    Oliver, C
    Prince, GA
    Hemming, VG
    Pfarr, DS
    Wang, SC
    Dormitzer, M
    OGrady, J
    Koenig, S
    Tamura, JK
    Woods, R
    Bansal, G
    Couchenour, D
    Tsao, E
    Hall, WC
    Young, JF
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (05) : 1215 - 1224
  • [9] Impact of palivizumab on expected costs of respiratory syncytial virus infection int preterm infants: Potential for savings
    Marchetti, A
    Lau, W
    Magar, R
    Wang, LP
    Devercelli, G
    [J]. CLINICAL THERAPEUTICS, 1999, 21 (04) : 752 - 766
  • [10] CONTROLLED TRIAL TO EVALUATE PROTECTION OF HIGH-RISK INFANTS AGAINST RESPIRATORY SYNCYTIAL VIRUS-DISEASE BY USING STANDARD INTRAVENOUS IMMUNE GLOBULIN
    MEISSNER, HC
    FULTON, DR
    GROOTHUIS, JR
    GEGGEL, RL
    MARX, GR
    HEMMING, VG
    HOUGEN, T
    SYNDMAN, DR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) : 1655 - 1658